| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 138,185 | 127,892 | 108,616 | 137,829 | | Cost of Revenue | 115,308 | 108,074 | 95,244 | 117,149 | | | Gross Profit | 22,877 | 19,818 | 13,372 | 20,680 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,851 | 4,293 | 2,791 | 5,140 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 18,026 | 15,525 | 10,581 | 15,540 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (101) | 107 | 16 | | Earnings Before Interest And Taxes | 11,958 | 22,725 | 17,693 | 24,237 | | Interest Expense | (5,532) | 5,532 | 5,236 | 7,687 | | Income Before Tax | 17,490 | 17,193 | 12,457 | 16,550 | | Income Tax Expense | 5,296 | 5,273 | 5,427 | 5,291 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 24,560 | 11,920 | 7,030 | 11,259 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,194 | 11,920 | 7,030 | 11,259 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,194 | $11,920 | $7,030 | $11,259 |
|
0.31% Nasdaq 0.00%
Income Statement
